Browse recalls
Search the latest U.S. consumer product recalls. Add the things you own to a watchlist to get notified.
43,170 recalls · page 53 of 2159
FDAApr 15, 2026 · #D-0428-2026
Class II — temporary health risk0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex bag, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC...
Drugs
FDAApr 15, 2026 · #D-0472-2026
Class II — temporary health riskClonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx Only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed ...
Drugs · 100060315
FDAApr 15, 2026 · #D-0440-2026
Class II — temporary health riskVancomycin HCI, 1.25 grams added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5083-01
Drugs · C274-000050857
FDAApr 15, 2026 · #D-0430-2026
Class II — temporary health risk0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freeflex bag, Rx only, BD Beckton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, D...
Drugs
FDAApr 15, 2026 · #D-0448-2026
Class II — temporary health riskGE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL (64.7%), Rx Only, Distributed by: GE Healthcare Inc., Marlborough, MA 01752 USA, NDC 0407-1414-91.
Drugs · 17333197, 17333198, 17396945…
FDAApr 15, 2026 · #D-0423-2026
Class II — temporary health riskLanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen International, S.A., Rodopi, Greece. Manufactured for: Cipla USA, Inc...
Drugs
FDAApr 15, 2026 · #D-0435-2026
Class II — temporary health risk5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-456-05, Unit of Sale NDC Number: 65219-4...
Drugs
FDAApr 15, 2026 · #D-0474-2026
Class II — temporary health riskClonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Systems and 4 Adhesive Covers, Rx only, Manufactured by: Actavis Laboratories UT Inc., Salt Lake City, UT 84108, Distributed ...
Drugs · 100053892
FDAApr 15, 2026 · #D-0439-2026
Class II — temporary health risknorepinephrine Bitartrate, 32mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5027-02
Drugs · C274-000050004
FDAApr 15, 2026 · #D-0437-2026
Class II — temporary health risk5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-458-05, Unit of Sale NDC Number: 6521...
Drugs
FDAApr 15, 2026 · #D-0436-2026
Class II — temporary health risk5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Unit of Use NDC: 65219-464-05, Unit of Sale NDC Number: 65219-4...
Drugs
FDAApr 15, 2026 · #D-0433-2026
Class II — temporary health risk0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freeflex bag, 1,000 mLx10, Fresenius Medical Care, Waltham, MA 02451, Distributed by: Fresenius Medica...
Drugs
FDAApr 15, 2026 · #D-0444-2026
Class II — temporary health riskXanax XR, alprazolam, extended-release tablets, 3 mg, 60 Tablets bottles, Rx only, Distributed by: Viatris Specialty LLC, Morgantown, WV 06506, U.S.A, Made in Ireland, NDC 58151-506-91
Drugs · 8177156
FDAApr 15, 2026 · #D-0443-2026
Class II — temporary health riskArtificial Tears Lubricant Eye Drops (glycerin 0.2%, hypromellose 0.2%, polyethylene glycol 400 1%), 0.5 oz bottles, Mfg: Geri-Care; Brooklyn, New York NDC 68788-7266-0
Drugs · F1924R
FDAApr 15, 2026 · #D-0438-2026
Class II — temporary health risknorepinephrine Bitartrate,16mg per 250mL 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5026-02
Drugs · C274-000049934
FDAApr 15, 2026 · #D-0425-2026
Class II — temporary health risk0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius Kabi USA, LLC ("Fresenius Kabi"), Lake Zurich, IL 60047, Unit of Use NDC: 65219-466-05, Unit of S...
Drugs
FDAApr 15, 2026 · #D-0429-2026
Class II — temporary health risk0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417 USA, Distributed by BD, Manufactured by Fresenius Kabi USA, LLC ("Fresenius Ka...
Drugs
FDAApr 15, 2026 · #D-0431-2026
Class II — temporary health risk0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freeflex bag, Rx only, BD Becton, Dickson and Company, 1 Beckton Drive, Franklin Lakes, NJ 07417, Distri...
Drugs
FDAApr 15, 2026 · #D-0446-2026
Class II — temporary health riskIsotretinoin Capsules, USP, 40 mg, 10 count Prescription Pacs, Rx only, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2436-15 (carton), NDC 0591-2436-45 (blister ...
Drugs
FDAApr 15, 2026 · #D-0442-2026
Class II — temporary health riskVancomycin HCL, 1 gram added to 250 mL, 0.9% Sodium Chloride Injection USP, Fagron Sterile Services, 8710 34th St. N. Wichita, KS 67226, NDC 71266-5082-01
Drugs · C274-000050987